Related Experiment Video
Updated: May 25, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
[Liver involvement in celiac disease in children]
Mircan Ozkan1, Laura Trandafir, Laura Bozomitu
1Facultatea de Medicină, Universitatea de Medicină şi Farmacie "Gr.T. Popa" Iaşi.
Celiac disease (CD) can manifest with liver issues. Screening for CD is crucial in children with unexplained liver dysfunction to ensure proper diagnosis and management.
Area of Science:
- Pediatric Gastroenterology
- Hepatology
- Autoimmune Diseases
Background:
- Celiac disease (CD) is an autoimmune disorder triggered by gluten, often presenting with diverse symptoms, including liver involvement.
- Atypical CD presentations can complicate diagnosis, especially in pediatric cases with unexplained liver dysfunction.
Purpose of the Study:
- To investigate liver manifestations in children diagnosed with CD.
- To evaluate the impact of a gluten-free diet (GFD) on liver function in these patients.
- To highlight the importance of immunological screening for CD in pediatric liver disease of unknown etiology.
Main Methods:
- A cohort of 120 children diagnosed with CD between 2007-2010 was studied.
- Liver function tests, viral hepatitis markers, and autoimmune hepatitis markers were assessed.
- Patients received GFD, hepatoprotective agents, and specific antivirals; transaminase levels were monitored.
Main Results:
- 10.14% of CD patients exhibited altered liver function at diagnosis, primarily elevated transaminases (57.14% of those with altered function).
- Hepatitis B surface antigen (HBsAg) was positive in 33.33% of cases.
- Four percent of patients with cryptogenetic hepatitis had undiagnosed CD, emphasizing the need for serological screening (AGA, AEA, ATGA).
Conclusions:
- CD should be considered and ruled out in pediatric patients presenting with liver disease of unknown origin before labeling it "cryptogenetic."
- Elevated transaminases without viral markers necessitate CD screening.
- Early CD diagnosis through serological testing is vital for managing associated liver dysfunction.
More Related Videos
10:27Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
09:44Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease II: Ulcerative Colitis